Biological active ingredients of traditional chinese herb astragalus membranaceus on treatment of diabetes: A systematic review

Mini-Reviews in Medicinal Chemistry

Volumn 15, Issue 4, 2015, Pages 315-329

  Zhang, Kai ^a,b   Pugliese, Michela ^a   Pugliese, Antonio ^a   Passantino, Annamaria ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Astragaloside; Astragalus flavonoids; Astragalus membranaceus; Astragalus polysaccharides; Astragalus saponins; Diabetes mellitus

Indexed keywords

ASERNESTIOSIDE A; ASERNESTIOSIDE B; ASTRAGALOSIDE IV; ASTRAGALUS MEMBRANACEUS EXTRACT; ASTRASIEVERSIANIN X; ATRAMEMBRANNIN I; CLOVERSAPONIN; CYCLOASTRAGENOL; CYCLODISSECTOSIDE; FLAVONOID; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; ISOASTRAGALOSIDE; MONGHOCOSIDE I; OLEIFOLOSIDE; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; SAPONIN; SITOSTEROL; SOYASAPONIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; HERBACEOUS AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; ENDOCRINE SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INSULIN RESISTANCE; NEUROPROTECTION; REGULATORY MECHANISM; TREATMENT OUTCOME; ANIMAL; ASTRAGALUS MEMBRANACEUS; CHEMISTRY; HUMAN;

ANIMALS; ASTRAGALUS MEMBRANACEUS; DIABETES MELLITUS; DRUGS, CHINESE HERBAL; FLAVONOIDS; HUMANS; POLYSACCHARIDES; SAPONINS;

EID: 84930977821     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: None     Document Type: Article

References (109)

1. Li, M. X.; Wang, W. X.; Xue, J. Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J. Ethnopharmacol., 2011, 133, 412-419.
2. Wu, F.; Chen, X. A review of pharmacological study on Astragalus membranaceus [Fisch.]Bge. J. Zhong Yao Cai, 2004, 27, 232-234.
3. Liu, Z. Q.; Li, Q. Z.; Qin, G. J. Effect of Astragalus injection on platelet function and plasma endothelin in patients with early stage diabetic nephropathy. J. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2001, 21, 274-276.
4. Grover, JK; Yadav, S; Vats V. Medicinal plants of India with antidiabetic potential. J. Ethnopharmacol., 2001, 81, 81-100.
5. Liu, M.; Tzeng, T. F.; Liou, S. S. A Chinese herbal decoction, Dang Gui Bu Xue Tang, prepared from Radix Astragali and Radix Angelicae sinensis, ameliorates insulin resistance induced by a high-fructose diet in rats. J. Evid.-Based Complement. Alt. Med., 2009, 2, 1-11.
6. Zhang, J. Q.; Xie, X. S.; Li, C.; Fu P. Systematic review of the renal protective effect of Astragalus membranaceus [root]on diabetic nephropathy in animal models. J. Ethnopharmacol., 2009, 126, 189-196.
7. Chen, Y. K.; Wang, D. Y.; Hu, Y. L.; Guo, Z.; Wamg, J.; Zhao, X.; Fan, Y.; Guo, L.; Yang, S.; Sai, F.; Xing, Y. Astragalus polysaccharide and oxymatrine can synergistically improve the immune efficacy of Newcastle disease vaccine in chicken. Int. J. Bio. Macromol., 2010, 46, 425-428.
8. Zhang, K.; Li, J. X.; Yang Z. Q.; Effects of fermented radix Astragalus extraction on growth, serum parameters of Broiler Chicken. J. Chin. Anim. Husb. Vet. Med., 2011, 38, 31-34.
9. Qin, Z.; Li, J. X.; Yang, Z. Q. Effects of fermentation Astragalus polysaccharides on experimental hepatic fibrosis. J. Anim. Vet. Adv., 2012, 11, 1195-1203.
10. Lau K. M., Lai K. K., Liu C. L. Synergistic interaction between Astragali Radix and Rehmanniae Radix in a chinese herbal formula to promote diabetic wound healing. J. Ethnopharmacol., 2012, 141, 250-256.
11. Agyemang, K.; Han, L.; Liu, E.; Zhang, Y.; Wang, T.; Gao X. Recent advances in Astragalus membranaceus anti-diabetic research: pharmacological effects of its phytochemical constituents. J. Evid. Based Complement Alternat. Med., 2013, 643-654.
12. Jin, M. J.; Zhao, K.; Huang, Q. S., Shang, P. Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int. J. Bio. Macromol., 2014, 64, 257-266.
13. Liu, M.; Wu, K.; Mao, X. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle. J. Ethnopharmacol., 2010, 127, 32-37.
14. Wang, N.; Zhang, D.; Mao, X.; Zou, F.; Jin, H., Ouyang J. Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes. Mol. Cell Endocrin., 2009, 307(1-2), 89-98.
15. Yan, Q. J.; Zhu, L. F.; Kumar, N. Characterisation of a novel monomeric lectin (AML) from Astragalus membranaceus with antiproliferative activity. J. Food Chem., 2010, 122, 589-595.
16. Mao, X. Q.; Wu, Y.; Wu, K.; Mao, X.; Wu, Y.; Ouyang J. Astragalus polysaccharide reduces hepatic endoplasmic reticulum stress and restores glucose homeostasis in a diabetic KKAy mouse model. J. Act. Pharmac. Sinic., 2007, 28, 1947-1956.
17. Wu, Y.; Ou-Yang, J. P.; Wu, K.; Wu, Y.; Ou-Yang, J. P.; Wu, K. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. J. Act. Pharmac. Sinic., 2005, 26, 345-352.
18. Liu, W.; Chen, J.; Zuo, W. J. A new isoflavane from processed Astragalus membranaceus. J. Chin. Chem. Lett., 2007, 18, 1092-1094.
19. Zhao, L. H.; Ma, Z. X.; Zhu, J.; Yu, X. H.; Weng D. P. Characterization of polysaccharide from Astragalus radix as the macrophage stimulator. J. Cell. Imm., 2011, 271, 329-334.
20. Kiyohara, H.; Uchida, T.; Takakiwa, M.; Matsuzaki, T.; Hada, N.; Takeda, T.; Shibata, T.; Yamada, H. Different contributions of side-chains in β-D-(1→3, 6)-galactans on intestinal Peyer's patchimmunomodulation by polysaccharides from Astragalus mongholics Bunge. J. Phytochem., 2010, 71, 280-293.
21. Gao, W. W.; Cao, L.; Li, Z.; Tong, J. M.; Sa, R. N. Effect of astraglan and astragaloside on the chicken lymphocyte proliferation. Chin J. Vet. Drug, 2001, 36(6), 16-18.
22. Chen, H. L.; Zhuo, B. S.; Li, D. F.; Chang, B. Y.; Zhang, J. X. Effect of astragalan on lymphocyte proliferation and signal molecules in the spleen of broilers. Chin. J. Vet. Sc., 2003, 10, 11-14.
23. Shao, P.; Zhao, L. H.; Chen, Z.; Pang, J. P. Regulation on maturation and function of dendritic cells by Astragalus mongholicus polysaccharides. J. Int. Immunopharmaco., 2006, 6, 1161-1166.
24. Kong, X. F.; Hu, Y. L.; Rui, R.; Wang, D. Y.; Li, X. R. Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody serum antibody titer after vaccination in chicken. J. Int. Immunopharmaco., 2004, 4, 975-982.
25. Qiu, Y.; Cui, B. A.; Hu, Y. L.; Dong, F. M.; Zhang, H. Y. The effect of four kinds of polysaccharides on the mRNA expression of IL-4 and IFN-in chicken's lymphocytes. J. Agric. Sci., 2009, 2, 32-35.
26. Li, R.; Chen, W. C.; Wang, W. P.; Tian, W. Y.; Zhang, X. G. Extraction, characterization of Astragalus polysaccharides and its immune modulating activities in rats with gastric cancer. J. Carbohydr. Polym., 2009, 78, 738-742.
27. Li, S. G.; Zhang, Y. Q. Characterization and renal protective effect of a polysaccharide from Astragalus membranaceus. J. Carbohydr. Polym., 2009, 78, 343-348.
28. Kitagawa, I.; Wang, H. K.; Saito, M.; Yoshikawa M. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus. [2]. Astragalosides I, II, and IV, acetylastragaloside I and isoastragalosides I and II. J. Chem. Pharm. Bull., 1983, 31(2), 698-708.
29. Kitagawa, I.; Wang, H. K.; Saito M. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus. [3]. Astragalosides III, V, and VI. J. Chem. Pharm. Bull., 1983, 31(2), 709-715.
30. Kitagawa, I.; Wang, H. K.; Yoshikawa, M. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus. Astragalosides VII and VIII. J. Chem. Pharm. Bull., 1983, 31(2), 716-722.
31. Qi, L. W.; Li, P.; Ren, M. T.; Li, Y. J. Application of highperformance liquid chromatography-electrospray ionization timeof-flight mass spectrometry for analysis and quality control of Radix Astragali and its preparations. J. Chromatogr., 2009 1216, 2087-2097.
32. He, Z. Q. Findlay J. A. Constituents of Astragalus membranaceus. J. Nat. Prod., 1991, 54(3), 810-815.
33. Sun, L. M.; Wang, X. L.; Deng, W. L.; Ding, L. S.; Peng, S. L. Chemical Constituentsfrom Astragalus ernestii. Chin. J. Nat. Med., 2011, 9(1), 38-41.
34. Isaev, M. I.; Imomnazarov, B. A.; Fadeev, Y. M. Triterpene glycostides of Astragalus and their genins XLⅡ. Cycloartanes of Astragalus tragacantha. J. Khim. Prir. Soedin., 1992, 3(4), 315-320.
35. Lu, L.; Wang, D. T.; Shi, Y.; Yin, Y.; Wei, L. B.; Zou, Y. C.; Huang, B.; Zhao, Y.; Wang, M.; Wan, H.; Li, C. J.; Diao J. X. Astragalus polysaccharide improves muscle atrophy from dexamethasone-and peroxide induced injury in vitro. Int J. Bio. Macromol., 2013, 61, 7-16.
36. Chen, W.; Li, Y. M.; Yu, M. H. Astragalus polysaccharides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation. J. Diabetes Complications, 2010, 24, 199-208.
37. Huang, L. M.; Liang, H.; Tian, Z. Effects of Astragali radix on renal function and its protein expression of IgA nephropathy in mice. Chin. J. Nat. Med., 2009, 7(1), 54-59.
38. Chen, C. Y.; Fu, Y. J.; Zu, Y. G.; Wang, W.; Mu, F. S.; Luo, M.; Li, C. Y.; Gu, C. B.; Zhao, C. J. Biotransformation of saponins to astragaloside IV from Radix Astragali by immobilized Aspergillus niger. J. Biocatal. Agric. Biotech., 2013, 2, 196-203.
39. Wen, Y. M. Review on the chemical composition of astragalus membranaceus. J. Chin. Trad. Pat. Med., 2006, 28(6), 879-883.
40. Gülcemal, D.; Masullo, M.; Napolitano, A.; Karayıldırım, T.; Bedir E.; Alankuş-Çalışkan, O.; Piacente, S. Oleanane glycosides from Astragalus tauricolus: Isolation and structural elucidation based on a preliminary liquid chromatography electrospray ionization tandem mass spectrometry profiling. J. Phytochem., 2013, 86, 184-194.
41. Yahara, S.; Kohjyouma, M.; Kohoda H. Flavonoid glycosides and saponins fromAstragalus shikokianus. J. Phytochem., 2000, 53, 469-471.
42. Zhang, Y. P.; Nie, M. K.; Shi, S. Y.; You, Q. P.; Guo J. F.; Liu, L. L. Integration of magnetic solid phase fishing and off-line twodimensional high performance liquid chromatography-diode array detector-mass spectrometry for screening and identification of human serum albumin binders from Radix Astragali. J. Food Chem., 2014, 146, 56-64.
43. Zhu, Y. Z.; Lu, S. H.; Okada Y.; Takata, M. Okuyama, T. Two new cycloartanetype glucosides, mongholicoside I and II, from the aerial part of Astragalus mongholicus. J. Chem. Pharm. Bull., 1992, 40(8), 2230-2232.
44. Horo, I.; Bedir, E.; Masullo M. Saponins from Astragalus hareftae. J. Phytochem., 2011, 84, 147-153.
45. Bedir, E.; Calis, I.; Zerbe, O.; Sticher O. Cyclocephaloside I: a novel cycloartane-type glycoside from Astragalus microcephalus. J. Nat. Prod., 1998, 61, 503-505.
46. Wang, H. K.; He, K.; Ling L. Q. Asernestioside C, a new minor saponin from the roots of Astragalus ernestii. First example of negative nuclear overhauser effect in the saponins. J. Chem. Pham. Bull., 1989, 37(8), 2041-2046.
47. Calis, I.; Zor, M.; Saracoglu, I.; Isimer, A.; Ruegger, H. Four novel cycloartane glycosides from Astragalus oleifolius. J. Nat. Prod., 1996, 59, 1019-1023.
48. Gülcemal, D.; Alankus-Caliskan, Ö.; Perrone, A.; Özgökce, F.; Piacente, S.; Bedir, E. Cycloartane glycosides from Astragalus aureus. J. Phytochem., 2011, 72, 761-768.
49. Ríos, L. J.; Waterman, P. G. A review of the pharmacology and toxicology of Astragalus. J. Phytother. Res., 1997, 11, 411-418.
50. Gan, L.; Han, X.; Chen, Y. The chemical investigation of Astragalus sieversianus. J. Phytochem. 1986, 25, 1437-1441.
51. Bedir, E.; Calis, I.; Aquino, R.; Piacente, S.; Pizza, C. Trojanoside H. A cycloartane-type secondary glycoside from the aerial parts of Astragalus trojanus. J. Phytochem., 1999, 51, 1017-1020.
52. Bedir, E.; Calis, I.; Aquino, R.; Piacente, S.; Pizza, C. Cycloartane triterpene glycosides from the roots of Astragalus brachypterus and Astragalus microcephalus. J. Nat. Prod., 1998, 61, 1469-1472.
53. Sukhina, I. A.; Mamedova, R. P.; Agzamova, M. A.; Isaev M. I. Triterpene glucosides of Astragalus and their genins. Cyclotrisectoside, the first trisdesmoside of cyclocephalogenin. Chem. J. Nat. Compd., 2007, 43, 159-161.
54. Mohamed, K. M.; Ohtani, K.; Kasai, R.; Yamasaki, K.; Oleanene glycosides from seeds of Trifolium alexandrinum. J. Phytochem. 1995, 40, 1237-1242.
55. Konoshima, T.; Kozuka, M.; Haruna, M.; Ito, K.; Kimura, T.; Tokuda, H. Studies on the constituents of leguminous plants XII. The structures of new triterpenoid saponins from Wistaria Branchybotrys. J. Chem. Pharm. Bull. 1989, 37, 2731-2735.
56. Konoshima, T.; Kozuka, M.; Haruna, M.; Ito, K. Constituents of leguminous plants, XIII. New triterpenoid saponins from Wistaria brachybotrys. J. Nat. Prod., 1991, 54, 830-836.
57. Zhao, M.; Duan, J. A.; Huang, W. Z.; Zhou R. H. Isoflavans and isoflavone from Astragalus hoantchy. J. China Pharm. Univ., 2002, 33(4), 274-276.
58. Song, C. Q.; Zheng, Z. R.; Liu, D.; Hund Z. B. Isoflavones from Astragalus membranaceus. J. Acta Bot. J. Sin., 1997, 39(8), 764-768.
59. Butayarov, A. V.; Batirov, E. K.; Tadzhibaev, M. M.; Yuldashev M. P. Flavonoids of Caragana alaica. Chem. J. Nat. Comp., 1999, 35(6), 628-630.
60. Sun, L. M.; Wang, X. L.; Deng W. L. Chemical Constituents from Astragalus ernestii. Chin. J. Nat. Med., 2010, 9(1), 38-41.
61. Yu, Q. T.; Li, P.; Bi, Z. M.; Luo, G.; Gao X. D. Two new saponins from the aerial part of Astragalus membranaceus var. Mongholicus. Chin. Chem. Lett., 2007, 18, 554-556.
62. Hirakawa, T.; Okawa, M.; Kinjo, J.; Nohara, T. Studies on legominous plants. Part 63. A new oleanane glucuronide obtained 14 from the aerial parts of Melilotus officinalis. J. Chem. Pharm. Bull., 2000, 48, 286-287.
63. Gülcemal, D.; Masullo, M.; Bedir, E.; Festa, M.; Karayıldırım, T.; Alankus-Çalıskan, Ö.; Piacente, S. Triterpene Glycosides From Astragalus angustifolius. J. Planta Med., 2012. 78, 720-729.
64. Sakamato, S.; Kofuji, S.; Kuroyanagi, M.; Ueno, A.; Sekita, S.; Saponins fromTrifolium repens. J. Phytochem., 1992, 31, 1773-1777.
65. Udayama, M., Ohkawa, M., Yoshida, N., Kinjo, J., Nohara, T. Structures of three new oleanene glucuronides isolated From Lathyrus palustris var. Pilosus and hepatoprotective activity. J. Chem. Pharm. Bull. 1998, 46, 1412-1415.
66. Huang, C. L.; Lu, Y. P. Effect of Astragalus injection on insulin resistance in auxiliary treating patients with diabetes mellitus type 2. Chin. J. Integr., 2003, 23, 779-780.
67. Yu, J.; Zhang, Y.; Sun, S., Shen, J.; Qiu, J.; Yin, X.; Yin, H.; Jiang S. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can. J. Phys. Pharm., 2006, 84, 579-587.
68. Zhang, Y.; Wu, C.; Cheng, J. Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-kappaB and I-kappaB in renal cortex of streptozotocin-induced diabetic rats. J. Ethnopharmacol., 2007, 114, 387-392.
69. Gui, D.; Huang, J.; Guo, Y.; Chen, J.; Chen, Y.; Xiao, W.; Liu, X.; Wang, N. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κBmediated inflammatory genes expression. J. Cytokine, 2013, 61(3), 970-977.
70. Nalbantsoy, A.; Nesil, T.; Dilsiz Ö. Y., Yilmaz-Dilsiz, O.;. Aksu, G.; Khan, S; Bedir E. Evaluation of the immunomodulatory properties in mice and in vitro anti-inflammatory activity of cycloartane type saponins from Astragalus species. J. Ethnopharmacol., 2012, 139, 574-581.
71. Nalbantsoy, A.; Nesil, T.; Erden, S.; Yilmaz-Dilsiz, Ö.; Aksu, G.; Khan, S.; Bedir E. Adjuvant effects of Astragalus saponins Macrophyllosaponin B and Astragaloside VII. J. Ethnopharmacol., 2011, 134, 897-903.
72. Yang, Z. G.; Sun, H. X.; Fang, W. H. Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice. J. Vaccine, 2005, 23, 5196-5203.
73. Susum, O.; Okuma, Y.; Uehara T.; Yamagishi, T.; Nomura Y. Astrapterocarpan isolated from Astragalus membranaceus inhibits proliferation of vascular smooth muscle cells. Euro. J. Pharmacol., 2005, 525, 41-47.
74. Zhang, B. Q.; Hu, S. J.; Qiu, L. H.; Zhu, J. H.; Xie, X. J.; Sun, J. Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine. J. Vascular Pharmacol., 2007, 46, 278-285.
75. Yin, X. X.; Zhang, Y. D.; Wu, H. W.; Zhu, X.; Zheng, X; Jiang, S.; Qiu, J. Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats. J. Pharmacol. Sci., 2004, 95, 256-266.
76. Yin, X.; Zhang, Y.; Yu, J; Zhang, P.; Shen, J.; Qiu, J.; Wu, H.; Zhu, X. The antioxidative effects of Astragalus saponin I protect against development of early diabetic nephropathy, J. Pharmacol. Sci., 2006, 101, 166-173.
77. Koh, E. H.; Kim, M.; Park, J. Peroxisome proliferator-activated receptor [PPAR]-α activation prevents diabetes in OLETF rats: comparison with PPAR-γ activation. J. Diabetes, 2003, 52(9), 2331-2337.
78. Xu, A.; Wang, H.; Hoo, R. L. C. Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. J. Endocrin., 2009, 150(2), 625-633.
79. Horo, I.; Bedir, E.; Masullo, M.; Saponins from Astragalus Hareftae (NAB.). J. Phytochem., 2012, 84, 147-153.
80. Li, R. F. Chemical constituents of Astragalus membranaceus Bge. var. mongholicus(Bge.) Hsiao. D. School of Traditional Chinese Materia Medica; Shenyang Pharmaceutical University: China, 2000.
81. Yu, D. H.; Bao, Y. M.; An, L. J.; Yang M. Protection of PC12 Cells against Superoxide-induced Damage by Isoflavonoids from Astragalus mongholicus. J. Biomed. Envir. Sci., 2009, 22, 50-54.
82. Jing, L.; Zhen, Z. Z.; Biao, C. H.; Review of Astragali radix. J. Chinese. Herb Med. 2011, 3(2), 90-105.
83. Kou, Y. H.; Tsai W. J.; Loke S. H. Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J. Ethnopharmacol., 2009, 122, 28-34.
84. Susumu, O.; Yasunobu, O.; Takashi, U., Takashi, Y.; Yasuyuki, N. Astrapterocarpan isolated from Astragalus membranaceusinhibits proliferation of vascular smooth muscle cells. Euro. J. Pharmacol., 2005, 525, 41-47.
85. Semmar, N.; Jay M.; Chemli R.; Chemical diversification trends in Astragalus caprinus(Leguminosae), based on the flavonoid pathway. J. Biochem. Syst. Eco., 2001, 29, 727-738.
86. Semmar, N.; Jay M.; Farman, M. Chemotaxonomic analysis of Astragalus caprinus (Fabaceae) based on the flavonic patterns. J. Biochem. Syst. Eco., 2005, 33, 187-200.
87. Chen, J. Li Y., Yang, L. Q.; Nan, Z. B.; Gao K. Biological activities of flavonoids from pathogenic-infected Astragalus adsurgens. J. Food Chem., 2012, 131, 546-551.
88. Chu, C.; Cai, H.; Ren, M.; Liu, E. H.; Li, B.; Qi, L. W.; Li, P. Characterization of novel astragaloside malonates from Radix Astragali by HPLC with ESI quadrupole TOF MS. J. Sep. Sci., 2010, 33(4-5), 570-581.
89. Xu, Q.; Ma, X. Q.; Liang, X. M. Determination of astragalosides in the roots of Astragalus spp. using liquid chromatography tandem atmospheric pressure chemical ionization mass spectrometry. J. Phytochem. Anal., 2007, 18(5), 419-427.
90. Wu, Y.; Ou-Yang, J. P.; Wu, K.; et al., Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. J. Acta Pharmacol. Sin., 2005, 26, 345-352.
91. Xiao, W. H; Han, L. J.; Shi, B. Isolation and purification of flavonoid glucosides from Radix Astragaliby high-speed countercurrent chromatography. J. Chromatogr., 2009, 877, 697-702.
92. Liu, W.; Chen, J.; Zuo, W. J.; Li, X.; Wang J. H. A new isoflavane from processed Astragalus membranaceus, J. Chin. Chem. Lett., 2007, 18, 1092-1094.
93. Sun F.; Duan, Z. H.; Pu J. Y. Studies on the chemical constituents of Machang Guitou. J. Coll. Tradit. Chin. Med., 2003, 26(2), 14-16.
94. Lee, E. J.; Yean, M. H.; Jung, H. S.; Kim J. S.; Kang, S. S. Phytochemical studies on Astragalus root (2)-flavonoids and a lignan. J. Nat. Prod. Sci., 2008, 14(2), 131-137.
95. Zhang, L. J.; Liu, H. K.; Hsiao, P. C.; Kuo, L. M. Lee, I. J. W. U. Çhiou, W. F.; Kuo, Y. H. New isoflavonoid glycosides and related constituents from astragali radix (Astragalus membranaceus) and their inhibitory activity on nitric oxide production. J. Agric. Food Chem. 2011, 59(4), 1131-1137.
96. Lin, L. Z.; He X. G.; Lindenmaier M.; Nolan, G.; Yang, J.; Cleary, M.; Qiu, S. X.; Cordell, G. A. Liquid chromatographyelectrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. Membranaceus. J. Chromatogr. A. 2000, 876(1-2), 87-95.
97. Wang W., Tanaka Y., Han Z. Proliferative response of mammary glandular tissue to formononetin. J. Nutr. Cancer., 1995, 23, 131-40.
98. Ji, Z. N.; Zhao, W. Y.; Liao G. R.; Choi, R. C.; Lo, C. K.; Dong T. T.; Tsim, K. W. In vitro estrogenic activity of formononetin by two bioassay systems. J. Gynecol. Endocrinol., 2006, 22, 578-84.
99. Shen, P.; Liu, M. H.; Ng, T. Y.; Chan Y. H.; Yong E. G. Differential effects of isoflavones, from Astragalus membranaceus and Pueraria Thomsonii, on the activation of PPARα, PPARγ, and adipocyte differentiation in vitro. J. Nutr., 2009, 136(4), 899-905.
100. Yang, H. J.; Zhang, D.; Zheng, M.; Fan, C. H. Resarch on the effects of Astragalus membranaceus on the free radicals of patients with diabetes Qi deficiency syndrome. J. Trad. Chin. Med., 2006, 24(4), 55-57.
101. Geng, Y. Clinical research on astragalus membranaceus acupoint injection of pre-diabetes intervention. D. Yunnan China: Yunnan college of traditional Chinese medicine, 2013.
102. Wang, C. Y; Wang, W. Y. To investigate treating effects of Astragalus membranaceus injection point injection in 30 clinical type 2 diabetics. Chin. J. Trad. Med. Sci. Techn., 2002, 9(3), 172-173.
103. Jin, J.; Zhu, Y. L.; Zeng, L. J. Meta analysis of the effectiveness and safety of HuangQi injection in treating diabetic nephropathy. In: 2013 National pharmaceutical academic communication: Proceedings of clinical pharmacy and pharmaceutical care research progress training classes. C., 2013, 155-177.
104. Ren, F.; Xu, H. Q. Systematic Review of the Effectiveness and Safety of Huang Qi Injection in Treating Diabetic Nephropathy. J. Bioactive Ingr. Trad. Chin. Herb. Mini-Rev. Med. Chem., 2015 1(15), 415.
105. Zhang, W. J.; Wojta, J.; Binder, B. R. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1and upregulates tissue-type plasminogen activator expression. J. Vasc. Res., 1997, 34(4), 273-280.
106. Zhang, W. J.; Hufnagl, P.; Binder, B. R.; Wojta, J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb. Haemost., 2003, 90(5), 904-914.
107. Fougère, B.; Wynn, S. Veterinary Herbal Medicine; Elsevier: Mosby, 2007.
108. Yang, C. Q.; Zhanc, L. P.; Sun, M. S.; Zhao, Y. H. Standard operating procedure for Astragalus membranaceus. J. Zhongguo Zhong Yao Za Zhi., 2006, 31(3), 191-194.
109. Yu, S. Y.; Ouyang, H. T.; Yang, J. Y.; Huang, X. L.; Yang, T.; Duan, J. P.; Cheng, J. P.; Chen, Y. X.; Yang, Y. J.; Qiong, P. Subchronic toxicity studies of Radix Astragali extract in rats and dogs. J. Ethnopharmacol., 2007, 110(2), 352-355.